Detalles de la búsqueda
1.
Combined exercise intervention in a mouse model of high-risk neuroblastoma: effects on physical, immune, tumor and clinical outcomes.
Exerc Immunol Rev
; 29: 86-110, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358366
2.
Superficial GLI1-amplified mesenchymal neoplasms: Expanding the spectrum of an emerging entity which reaches the realm of dermatopathology.
J Cutan Pathol
; 50(6): 487-499, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316249
3.
MicroRNA-19b Plays a Key Role in 5-Fluorouracil Resistance and Predicts Tumor Progression in Locally Advanced Rectal Cancer Patients.
Int J Mol Sci
; 23(20)2022 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36293302
4.
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.
Int J Mol Sci
; 23(21)2022 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36362083
5.
Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer.
Int J Mol Sci
; 22(24)2021 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34948097
6.
In search of an evidence-based strategy for quality assessment of human tissue samples: report of the tissue Biospecimen Research Working Group of the Spanish Biobank Network.
J Transl Med
; 17(1): 370, 2019 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31718661
7.
Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma.
Br J Cancer
; 115(3): 322-31, 2016 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27404455
8.
Activation of MET pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancer.
J Transl Med
; 13: 282, 2015 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26319934
9.
Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer.
BMC Pulm Med
; 15: 132, 2015 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-26502926
10.
Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma.
Int J Mol Sci
; 16(8): 19447-57, 2015 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26287187
11.
DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
BMC Cancer
; 14: 965, 2014 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25515240
12.
Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in Spain.
Cancer Med
; 13(3): e6827, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38213074
13.
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer.
Cancers (Basel)
; 15(7)2023 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046799
14.
CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer.
J Clin Med
; 11(6)2022 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35329936
15.
Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer.
Cancers (Basel)
; 14(24)2022 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551522
16.
mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer.
Mol Cancer Res
; 20(7): 1108-1121, 2022 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348729
17.
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer.
Sci Adv
; 8(20): eabk2746, 2022 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35594351
18.
Comprehensive Approach to Genomic and Immune Profiling: Insights of a Real-World Experience in Gynecological Tumors.
Diagnostics (Basel)
; 12(8)2022 08 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36010253
19.
Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients.
Cancers (Basel)
; 13(19)2021 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34638487
20.
Expression of Phosphorylated BRD4 Is Markedly Associated with the Activation Status of the PP2A Pathway and Shows a Strong Prognostic Value in Triple Negative Breast Cancer Patients.
Cancers (Basel)
; 13(6)2021 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33809005